Clinical trial
A Pilot Study of Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patient With Diabetic Foot Ulcer Wagner 3-4
NCT03615755 is registered in ClinicalTrials.gov with Hendry Irawan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patient With Diabetic Foot Ulcer Wagner 3-4
- Lead sponsor
- Hendry Irawan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 27, 2016
- Completion date
- March 31, 2017
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer, hyperbaric oxygen therapy, type ii diabetes mellitus